img

Global Irritable Bowel Syndrome Treatment Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Irritable Bowel Syndrome Treatment Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Irritable bowel syndrome (IBS) is a common condition that affects the digestive system. It causes symptoms like stomach cramps, bloating, diarrhoea and constipation. These tend to come and go over time, and can last for days, weeks or months at a time. It's usually a lifelong problem.
Irritable Bowel Syndrome Treatment Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Irritable Bowel Syndrome Treatment Drug market is projected to reach US$ 4348.9 million in 2029, increasing from US$ 3515 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2029. Demand from Hospitals and Specialty Clinics are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Irritable Bowel Syndrome Treatment Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca
Segment by Type
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others

Segment by Application


Hospitals
Specialty Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Irritable Bowel Syndrome Treatment Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Irritable Bowel Syndrome Treatment Drug introduction, etc. Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Irritable Bowel Syndrome Treatment Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Irritable Bowel Syndrome Treatment Drug
1.1 Irritable Bowel Syndrome Treatment Drug Market Overview
1.1.1 Irritable Bowel Syndrome Treatment Drug Product Scope
1.1.2 Irritable Bowel Syndrome Treatment Drug Market Status and Outlook
1.2 Global Irritable Bowel Syndrome Treatment Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2018-2029)
1.4 Global Irritable Bowel Syndrome Treatment Drug Historic Market Size by Region (2018-2024)
1.5 Global Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029)
1.6.1 North America Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029)
1.6.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029)
1.6.4 Latin America Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029)
2 Irritable Bowel Syndrome Treatment Drug Market by Type
2.1 Introduction
2.1.1 Antibiotics
2.1.2 Amino Salicylates
2.1.3 Corticosteroids
2.1.4 Immunomodulators
2.1.5 Others
2.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Irritable Bowel Syndrome Treatment Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Type (2018-2029)
3 Irritable Bowel Syndrome Treatment Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialty Clinics
3.1.3 Other
3.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Irritable Bowel Syndrome Treatment Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue Breakdown by Application (2018-2029)
4 Irritable Bowel Syndrome Treatment Drug Competition Analysis by Players
4.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Treatment Drug as of 2022)
4.3 Date of Key Players Enter into Irritable Bowel Syndrome Treatment Drug Market
4.4 Global Top Players Irritable Bowel Syndrome Treatment Drug Headquarters and Area Served
4.5 Key Players Irritable Bowel Syndrome Treatment Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Irritable Bowel Syndrome Treatment Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbvie Inc.
5.1.1 Abbvie Inc. Profile
5.1.2 Abbvie Inc. Main Business
5.1.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.1.4 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Abbvie Inc. Recent Developments
5.2 Bristol Myers Squibb
5.2.1 Bristol Myers Squibb Profile
5.2.2 Bristol Myers Squibb Main Business
5.2.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.2.4 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Bristol Myers Squibb Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.3.4 Roche Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.4.4 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Johnson & Johnson Recent Developments
5.5 Pfizer Inc.
5.5.1 Pfizer Inc. Profile
5.5.2 Pfizer Inc. Main Business
5.5.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.5.4 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Pfizer Inc. Recent Developments
5.6 Prometheus Laboratories Inc. (Nestle)
5.6.1 Prometheus Laboratories Inc. (Nestle) Profile
5.6.2 Prometheus Laboratories Inc. (Nestle) Main Business
5.6.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.6.4 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Prometheus Laboratories Inc. (Nestle) Recent Developments
5.7 Bausch Health
5.7.1 Bausch Health Profile
5.7.2 Bausch Health Main Business
5.7.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.7.4 Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Bausch Health Recent Developments
5.8 Takeda Pharmaceutical Ltd
5.8.1 Takeda Pharmaceutical Ltd Profile
5.8.2 Takeda Pharmaceutical Ltd Main Business
5.8.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.8.4 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Takeda Pharmaceutical Ltd Recent Developments
5.9 Biogen
5.9.1 Biogen Profile
5.9.2 Biogen Main Business
5.9.3 Biogen Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.9.4 Biogen Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Biogen Recent Developments
5.10 AstraZeneca
5.10.1 AstraZeneca Profile
5.10.2 AstraZeneca Main Business
5.10.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
5.10.4 AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) & (2018-2024)
5.10.5 AstraZeneca Recent Developments
6 North America
6.1 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Irritable Bowel Syndrome Treatment Drug Market Dynamics
11.1 Irritable Bowel Syndrome Treatment Drug Industry Trends
11.2 Irritable Bowel Syndrome Treatment Drug Market Drivers
11.3 Irritable Bowel Syndrome Treatment Drug Market Challenges
11.4 Irritable Bowel Syndrome Treatment Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Irritable Bowel Syndrome Treatment Drug Market Size Share by Region (2018-2024)
Table 4. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Irritable Bowel Syndrome Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Irritable Bowel Syndrome Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Irritable Bowel Syndrome Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Irritable Bowel Syndrome Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Irritable Bowel Syndrome Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Irritable Bowel Syndrome Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Irritable Bowel Syndrome Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Irritable Bowel Syndrome Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Irritable Bowel Syndrome Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Irritable Bowel Syndrome Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Irritable Bowel Syndrome Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Irritable Bowel Syndrome Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Treatment Drug as of 2022)
Table 39. Date of Key Players Enter into Irritable Bowel Syndrome Treatment Drug Market
Table 40. Global Irritable Bowel Syndrome Treatment Drug Key Players Headquarters and Area Served
Table 41. Irritable Bowel Syndrome Treatment Drug Product Solution and Service
Table 42. Global Irritable Bowel Syndrome Treatment Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbvie Inc. Basic Information List
Table 45. Abbvie Inc. Description and Business Overview
Table 46. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Abbvie Inc. (2018-2024)
Table 48. Abbvie Inc. Recent Developments
Table 49. Bristol Myers Squibb Basic Information List
Table 50. Bristol Myers Squibb Description and Business Overview
Table 51. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Bristol Myers Squibb (2018-2024)
Table 53. Bristol Myers Squibb Recent Developments
Table 54. Roche Basic Information List
Table 55. Roche Description and Business Overview
Table 56. Roche Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Roche (2018-2024)
Table 58. Roche Recent Developments
Table 59. Johnson & Johnson Basic Information List
Table 60. Johnson & Johnson Description and Business Overview
Table 61. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Johnson & Johnson (2018-2024)
Table 63. Johnson & Johnson Recent Developments
Table 64. Pfizer Inc. Basic Information List
Table 65. Pfizer Inc. Description and Business Overview
Table 66. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Pfizer Inc. (2018-2024)
Table 68. Pfizer Inc. Recent Developments
Table 69. Prometheus Laboratories Inc. (Nestle) Basic Information List
Table 70. Prometheus Laboratories Inc. (Nestle) Description and Business Overview
Table 71. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Prometheus Laboratories Inc. (Nestle) (2018-2024)
Table 73. Prometheus Laboratories Inc. (Nestle) Recent Developments
Table 74. Bausch Health Basic Information List
Table 75. Bausch Health Description and Business Overview
Table 76. Bausch Health Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Bausch Health (2018-2024)
Table 78. Bausch Health Recent Developments
Table 79. Takeda Pharmaceutical Ltd Basic Information List
Table 80. Takeda Pharmaceutical Ltd Description and Business Overview
Table 81. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Takeda Pharmaceutical Ltd (2018-2024)
Table 83. Takeda Pharmaceutical Ltd Recent Developments
Table 84. Biogen Basic Information List
Table 85. Biogen Description and Business Overview
Table 86. Biogen Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of Biogen (2018-2024)
Table 88. Biogen Recent Developments
Table 89. AstraZeneca Basic Information List
Table 90. AstraZeneca Description and Business Overview
Table 91. AstraZeneca Irritable Bowel Syndrome Treatment Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Drug Business of AstraZeneca (2018-2024)
Table 93. AstraZeneca Recent Developments
Table 94. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 95. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 97. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 100. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share by Region (2018-2024)
Table 102. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share by Region (2024-2029)
Table 103. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 105. Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 108. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 109. Irritable Bowel Syndrome Treatment Drug Market Trends
Table 110. Irritable Bowel Syndrome Treatment Drug Market Drivers
Table 111. Irritable Bowel Syndrome Treatment Drug Market Challenges
Table 112. Irritable Bowel Syndrome Treatment Drug Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome Treatment Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Irritable Bowel Syndrome Treatment Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Antibiotics
Figure 11. Global Antibiotics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Amino Salicylates
Figure 13. Global Amino Salicylates Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Corticosteroids
Figure 15. Global Corticosteroids Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Immunomodulators
Figure 17. Global Immunomodulators Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global Irritable Bowel Syndrome Treatment Drug Market Size Share by Type: 2022 & 2029
Figure 21. North America Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 22. Europe Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 24. Latin America Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 26. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Specialty Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Global Irritable Bowel Syndrome Treatment Drug Market Size Share by Application: 2022 & 2029
Figure 30. North America Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 31. Europe Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 32. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 33. Latin America Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 34. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 35. Irritable Bowel Syndrome Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Irritable Bowel Syndrome Treatment Drug Market Share in 2022
Figure 37. North America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2018-2029)
Figure 38. United States Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Canada Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 40. Germany Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 41. France Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 42. U.K. Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Italy Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 44. Russia Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 45. Nordic Countries Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 46. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share by Region (2018-2029)
Figure 47. China Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Japan Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 49. South Korea Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 51. India Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 52. Australia Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Latin America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2018-2029)
Figure 54. Mexico Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 55. Brazil Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Country (2018-2029)
Figure 57. Turkey Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 59. UAE Irritable Bowel Syndrome Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries